| The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications JD McFadyen, H Stevens, K Peter Circulation research 127 (4), 571-587, 2020 | 659 | 2020 |
| Current and future antiplatelet therapies: emphasis on preserving haemostasis JD McFadyen, M Schaff, K Peter Nature Reviews Cardiology 15 (3), 181-191, 2018 | 279 | 2018 |
| Platelet-derived microvesicles in cardiovascular diseases MTK Zaldivia, JD McFadyen, B Lim, X Wang, K Peter Frontiers in cardiovascular medicine 4, 74, 2017 | 173 | 2017 |
| Dissociation of C-reactive protein localizes and amplifies inflammation: evidence for a direct biological role of C-reactive protein and its conformational changes JD McFadyen, J Kiefer, D Braig, J Loseff-Silver, LA Potempa, ... Frontiers in immunology 9, 1351, 2018 | 171 | 2018 |
| Platelets are not just for clots JD McFadyen, ZS Kaplan Transfusion medicine reviews 29 (2), 110-119, 2015 | 136 | 2015 |
| The class II PI 3-kinase, PI3KC2α, links platelet internal membrane structure to shear-dependent adhesive function JK Mountford, C Petitjean, HWK Putra, JA McCafferty, NM Setiabakti, ... Nature communications 6 (1), 6535, 2015 | 91 | 2015 |
| C-reactive protein and its structural isoforms: an evolutionary conserved marker and central player in inflammatory diseases and beyond JD McFadyen, J Zeller, LA Potempa, GA Pietersz, SU Eisenhardt, K Peter Vertebrate and invertebrate respiratory proteins, lipoproteins and other …, 2020 | 77 | 2020 |
| Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4 ZS Kaplan, A Zarpellon, I Alwis, Y Yuan, J McFadyen, M Ghasemzadeh, ... Nature communications 6 (1), 7835, 2015 | 77 | 2015 |
| Neutrophil macroaggregates promote widespread pulmonary thrombosis after gut ischemia Y Yuan, I Alwis, MCL Wu, Z Kaplan, K Ashworth, D Bark Jr, A Pham, ... Science Translational Medicine 9 (409), eaam5861, 2017 | 74 | 2017 |
| Bortezomib-based antibody depletion for refractory autoimmune hematological diseases S Ratnasingam, PA Walker, H Tran, ZS Kaplan, JD McFadyen, H Tran, ... Blood Advances 1 (1), 31-35, 2016 | 70 | 2016 |
| Differentiating haemostasis from thrombosis for therapeutic benefit JD McFadyen, SP Jackson Thrombosis and haemostasis 110 (11), 859-867, 2013 | 64 | 2013 |
| Targeting activated platelets: a unique and potentially universal approach for cancer imaging ML Yap, JD McFadyen, X Wang, NA Zia, JD Hohmann, M Ziegler, Y Yao, ... Theranostics 7 (10), 2565, 2017 | 56 | 2017 |
| Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets L Ju, JD McFadyen, S Al-Daher, I Alwis, Y Chen, LL Tønnesen, ... Nature communications 9 (1), 1087, 2018 | 55 | 2018 |
| C-reactive protein, immunothrombosis and venous thromboembolism C Dix, J Zeller, H Stevens, SU Eisenhardt, KSCT Shing, TL Nero, ... Frontiers in Immunology 13, 1002652, 2022 | 54 | 2022 |
| Thromboembolic and bleeding complications in transcatheter aortic valve implantation: insights on mechanisms, prophylaxis and therapy MP Ranasinghe, K Peter, JD McFadyen Journal of Clinical Medicine 8 (2), 280, 2019 | 51 | 2019 |
| Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce JP Vogel, B Tendal, M Giles, C Whitehead, W Burton, S Chakraborty, ... Australian and New Zealand Journal of Obstetrics and Gynaecology 60 (6), 840-851, 2020 | 46 | 2020 |
| Lysophosphatidylcholine is a major component of platelet microvesicles promoting platelet activation and reporting atherosclerotic plaque instability P Diehl, F Nienaber, MTK Zaldivia, J Stamm, PM Siegel, NA Mellett, ... Thrombosis and Haemostasis 119 (08), 1295-1310, 2019 | 46 | 2019 |
| Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases ML Yap, JD McFadyen, X Wang, M Ziegler, YC Chen, A Willcox, ... Theranostics 9 (4), 1154, 2019 | 46 | 2019 |
| Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases J Zeller, B Bogner, JD McFadyen, J Kiefer, D Braig, G Pietersz, G Krippner, ... Pharmacology & Therapeutics 235, 108165, 2022 | 39 | 2022 |
| Novel antithrombotic drugs on the horizon: the ultimate promise to prevent clotting while avoiding bleeding JD McFadyen, K Peter Circulation Research 121 (10), 1133-1135, 2017 | 39 | 2017 |
